On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
On Jul. 13, 2020, a team of researchers from Oxford University, the Rosalind Franklin Institute, Diamond Light Source…
On Jul. 13, 2020, Lonza and Junshi Biosciences announced that the first healthy volunteer had been dosed in…
On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesï¾’ four investigational vaccine candidates from…
On Jul. 13, 2020, Meridian Bioscience announced it had launched a high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for the…
On Jul. 9, 2020, Atos announced that the Biocomputing Unit at the Spanish National Center for Biotechnology (CNB),…
On Jul. 9, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that it is partnering with Albany…
On Jul. 8, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that it had created a registry…
On Jul. 8, 2020, Kleo Pharmaceuticals announced that it had received a $5 million grant from the Bill…
On Jul. 8, 2020, NanoViricides announced that excellent safety and tolerability of the drug candidates it is developing…
On Jul. 7, 2020, the FDA alerted clinical laboratory staff and health care providers of an increased risk…
On Jul. 7, 2020, the FDA alerted clinical laboratory staff and health care providers of an increased risk…
On Jul. 7, 2020, Cerus announced study results that demonstrated the INTERCEPT Blood System inactivates SARS-CoV-2, the causative…
On Jul. 7, 2020, Innovation Pharma reported the latest developments related to research into Brilacidin as a potential…
On Jul. 6, 2020, the European Investment Bank (EIB) and CureVac announced they had entered into a $75…
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…
On Jul. 6, 2020, Anixa Biosciences announced that it and partner OntoChem had completed the initial in silico…
On Jul. 6, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
On Jul. 3, 2020, Gilead Sciences announced the European Commission had granted conditional marketing authorization for Vekluryï¾® (remdesivir)…
On Jul. 2, 2020, scientists from Duke University, Los Alamos National Laboratory and La Jolla Institute for Immunology…
On Jul. 2, 2020, Maxim Biomedical announced plans to produce and market as many as 3 million Maxim…
On Jul. 2, 2020, Ceres Nanosciences and its collaborators at George Mason University announced they had have developed…
On Jul. 1, 2020, in a Perspective for the New England Journal of Medicine, members of the NIHï¾’s…
On Jul. 1, 2020, T2 Biosystems announced completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2…
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
On Jul. 1, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for…
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
On Jun. 29, 2020, Luminex announced that the company had submitted an Emergency Use Authorization request to the…